According to the Banff criteria for kidney allografts, isolated vascular or "v" lesions are defined as intimal inflammation, age-inappropriate fibro-intimal hyperplasia, or both, without the presence of associated interstitial T cell-mediated rejection (TCMR). In general, these lesions portend a worse outcome for kidney allografts, particularly in those where the "v" lesions are identified in patients with coexistent donor specific antibodies (DSA) or later after transplantation. Although affected arteries are rarely sampled in liver allograft biopsies, we identified nine patients at a mean of 1805 days posttransplantation and compared these to matched controls. Almost half (4 of 9) of the study patient biopsies showed inflammatory arteritis associated with focal or diffuse C4d positivity, which was not observed in matched controls. One "v" lesion patient progressed to rejection-related graft failure and two developed moderate/severe TCMR in subsequent biopsies, whereas only one rejection episode occurred in follow-up biopsies, and no rejection-related deaths or graft failures were detected in controls. In conclusion, patients with liver allograft isolated "v" lesions should undergo further evaluation and closer follow-up for impending TCMR and/or underlying co-existent chronic antibody-mediated rejection (AMR).
| INTRODUC TI ON
Arterial inflammation and/or fibrosis can occur in renal allografts from patients with or without DSA and/or with or without interstitial changes of T cell-mediated rejection (TCMR) and/or antibodymediated rejection (AMR) (reviewed previously 1 ). In kidney allograft biopsies, the term "isolated vascular v lesions" is used to describe biopsies when the arterial changes occur in the absence of interstitial inflammation and/or tubulitis. Although any isolated "v" lesion independently predicts premature allograft failure when compared to matched allografts without such lesions, DSA-positive patients with isolated "v" lesions and those with any evidence of accompanying AMR are the most severely affected. [1] [2] [3] [4] [5] [6] [7] [8] Like renal allografts, 4, 6, 9 acute and chronic TCMR in liver allografts may cause arterial pathology. 10 However, (1) portal tracts or peri-hilar tissue containing large to medium-sized muscular arteries with elastic lamina used to diagnose "v" lesions are uncommonly sampled in routine peripheral liver allograft biopsies and therefore finding such lesions is rare; and (2) acute and chronic AMR are just recently recognized entities in liver allografts. 11 We investigated the significance of isolated "v" lesions in liver allografts after detecting the index case in a protocol screening biopsy from an asymptomatic pediatric recipient. This patient also had normal liver injury tests and was being considered for an immunosuppression minimization trial (Patient S9, Figure 1I ). This completely unexpected observation led to clinical team uncertainty about proper management, similar to the challenge encountered with renal allografts. [1] [2] [3] [4] [5] [6] [7] [8] Searching the liver allograft biopsy database, we identified eight additional cases with similar histopathologic findings. Despite the small number of patients with this rare lesion, several patients with isolated "v" lesions developed either more severe TCMR in subsequent biopsies or rejection-related graft failure, F I G U R E 1 Hematoxylin and eosin (H&E) stained liver sections from the nine study patients with isolated arterial "v" lesions observed in their allograft liver biopsies (A -I). Arterial lesions observed in the study patients consisted predominantly of intimal hyperplasia, often extending into the lumen, causing substantial stenosis/obliteration of the vessel. Several of the patients (S2, S6, S8, and S9) showed obvious inflammatory arteritis by H&E evaluation; others (S1, S3, S4, S5, and S7) showed intimal hyperplasia without obvious inflammation. Some patient biopsies (S4 and S7) showed more apparent inflammatory arteritis with IHC staining for CD3 and CD68 ( Figure 2 ). The majority of the patients had minimal other histopathological findings and relatively normal hepatic laboratory profiles to suggest the presence of graft rejection. Patients S3 and S6 progressed to acute cellular rejection in their next liver biopsies. Patients S1, S3, S4, and S7 had either focal or diffuse C4d positivity within portal capillaries ( Figure 2 ). Patient S9 was the 13-year-old male pediatric patient that initiated this study and was being evaluated for possible weaning of his immune suppression when this lesion was detected in his liver biopsy whereas no rejection-related events, graft failures or deaths were observed in the negative control group without "v" lesions. In addition, four study patients showed at least focal portal microvascular C4d positivity, suggestive of underlying chronic AMR. 11 Importantly, affected recipients often show little or no serological evidence of allograft injury or dysfunction until very late in the course of events.
| MATERIAL AND ME THODS

| Study population
The study population included an index case and eight additional cases identified by searching the database at the University of was not conducted on patient 9 because of the unavailability of additional sections.
| Pathology studies
| Statistical methods
Data were analyzed using SigmaPlot software (SPSS, Chicago, IL). had received induction immunotherapy with thymoglobulin, and this difference was statistically significant (P < .001) when compared to negative controls. All study patients and a majority of controls were on maintenance immune suppression with tacrolimus (3-6 mg daily).
| Histologic identification of arteriopathy correlated with impending T cell-mediated rejection (TCMR), C4d positivity, and increased allograft fibrosis
A majority of study patients with isolated "v" lesions had liver biopsies that were either negative or indeterminate for acute TCMR (ie, RAI scores were between 0 and 2, Table 2 ). Their corresponding liver-related laboratory studies were within the normal range or only mildly elevated (median results ≤ 2X the upper limit of normal)
( Table 1 ). The matched negative controls had significantly higher alkaline phosphatase (P = .020), GGT (P = .025), and ALT (P = .045) levels than the study patients due to biliary complications (eg, patients C1a, C2b, C3a, and C6a; Tables 1 and 2 ). Only study patient 3 (S3) had transaminase levels that were greater than two times the upper limit of normal, and this patient progressed to graft failure attributed to TCMR (Table 1) .
Hepatic artery branch histopathology changes from all nine study patients are shown in Figure 1 ; the majority (6 of 9) showed obvious arterial intimal lymphohistiocytic inflammation, which was confirmed with CD3 and often CD68 IHC stains ( Figure 2 ). Arteries with "v" lesions were scored similar to renal allografts (ie, v1, v2, or v3) ( Table 3 , Figures 1 and 2) . 13, 14 The remaining three study patients (S1, S3, and S5) showed severe, age-inappropriate concentric fibro-intimal hyperplasia with minimal or no inflammation. Several study patients also showed biliary senescence changes (S1, S2, and S7), ductopenia (patients S3 and S6; data not shown), and fibrosis (Table 3) , suggestive of chronic rejection.
All study patients, except patient S1, had negative pretransplant for DQ2 (MFI: greater than 10 000) and DQ3 (MFI: 5000). Since DSA evaluations were not available for most patients, we used C4d staining as a surrogate test for a possible association of isolated "v"
lesions with chronic AMR (Table 3 and Figure 2 ). Previous studies show a strong correlation between DSA and liver microvascular C4d deposition. 11, 15, 16 Four of eight patients (S9 was not stained for C4d, as additional liver tissue was unavailable) with isolated "v" lesions showed at least focal positivity for C4d (10-50% capillaries staining), including the study patient who experienced rejection-related graft failure, compared to 0 of 18 in the control group (Table 3) .
According to the recently developed Banff criteria for "probable"
chronic AMR, at least focal C4d deposition and moderate portal/ periportal, sinusoidal and/or perivenular fibrosis is required to establish the diagnosis. 11 The majority (3 of 4) of the study patients with C4d positivity met this criterion in the index biopsy. Several had perivenular fibrosis/sclerosis either noted in their pathology report or identified by retrospective Masson's trichrome stains (Table 3) .
| Patient and graft follow-up
Isolated "v" lesions were suggestive of probable underlying chronic active TCMR and/or chronic AMR and in some cases presaged clinically significant TCMR: two study patients (S3 and S6)
progressed to moderate TCMR on follow-up liver biopsy and study patient 7 (S7) had persistent moderate to severe TCMR diagnosed in their next four subsequent biopsies, extending over a period of seven months. Graft and patient survival data showed one study group patient (S3) developed graft failure and underwent retransplantation for rejection and "biliary complications" then died five years later due to recurrent cirrhosis, allograft failure, and kidney failure. Study patient 7 died from metastatic cholangiocarcinoma.
Five matched negative controls are also deceased from causes not related to rejection (Table 2) . Two other patients (S4 and S5) were not subjected to re-biopsy after the index isolated "v" lesion diagnosis and appear to have been lost to follow-up. Therefore, we were unable to determine if they progressed to more advanced rejection episodes. One control patient (C2b) developed an episode of rejection during and after his index biopsy (Table 2 ). There were four rejection-related events observed in the study patients and only one in the negative control group (P = .029).
| D ISCUSS I ON
This study was triggered by uncertainty about classification and the appropriate clinical response to isolated obliterative and/or inflammatory arteriopathy in otherwise stable liver allograft recipients. preexisting donor-related atherosclerosis has to be considered in the differential diagnosis.
Liver allograft arteriopathic lesions are usually encountered and studied in failed allografts removed at the time of hepatic retransplantation. In this series, however, they were serendipitously discovered on "peripheral" core needle biopsies in patients without typical, active TCMR and relatively normal liver-related laboratory studies (Table 1 and Figure 1 ). The small number of study patients makes it very difficult to make any strong recommendations, but even in this small cohort the implications of liver allograft isolated "v" lesions appear similar to kidney and heart allografts. In this study, 1 of 5 positive controls and 1 of 9 of study patients experienced rejection-related graft failure, whereas no rejectionrelated graft failures were detected in the negative controls.
Overall, four rejection-related events were observed in study patients and only one was observed in the negative controls (P = .029).
Some study patients (S3 and S6) showed other features of chronic The conjugated (direct) bilirubin was 0.0.
TA B L E 1 (Continued)
TA B L E 2 Graft survival days (GSD), histopathological findings, and patient status, of index biopsies and matched controls Table 2 ); three of four of these C4d-positive patients also had moderate periportal, sinusoidal or perivenular fibrosis (Tables 2 and 3 ). The study patient (S4) that was positive for class II DSA (DQ2, DQ3) would have met the criteria for a diagnosis of probable chronic AMR; two additional study patients (S3 and S7) only met three of the four criteria since they were not tested for the presence of DSA. However, more studies than not, have shown strong correlation between serum DSA and liver biopsy microvascular C4d deposition on FFPE tissues (reviewed previously 11 ). we recommend that all cases with isolated "v" lesions should also be examined for C4d staining, other features of chronic AMR, 11, 16, 32, 33 and evidence of serum DSA (with Luminex-based, single-antigen beads). Should DSA and C4d testing yield negative results, underlying or developing TCMR should be considered.
The obvious limitations of this study are small sample size and the presence of only one patient being appropriately tested for serum DSA. These limitations were impossible to avoid because of the rarity of the lesion and the lack of DSA testing after liver transplantation in the era examined. The scarcity of DSA testing in liver allograft recipients, even when AMR was detected or suggested by the biopsy findings, likely reflects a bias against establishing an AMR diagnosis in this population even at an institution that has been regularly suggesting the diagnosis for more than two decades. 34 Unfortunately, two study patients (S1 and S7) that had C4d positivity in their liver biopsies, were only tested for the presence of class I DSA when it is known that chronic AMR is strongly linked to de novo class II DSA. 16, 33, 35 More data on this topic is needed and it will be necessary to conduct a multi-center study, similar to the approach used with renal allografts. 2 In conclusion, these study results raised several important issues, similar to renal allografts: (1) isolated "v" lesions are often 
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